Your browser doesn't support javascript.
loading
Cost-effectiveness of prophylactic emicizumab versus prophylactic recombinant factor VIII in patients with moderate or mild hemophilia A without inhibitors in the United States.
Potnis, Kunal C; Viswanathan, Giri; Bona, Robert D; Ito, Satoko; Kempton, Christine L; Pandya, Ankur; Krumholz, Harlan M; Goshua, George.
Affiliation
  • Potnis KC; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Viswanathan G; Yale College, New Haven, Connecticut, USA.
  • Bona RD; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.
  • Ito S; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.
  • Kempton CL; Department of Hematology and Medical Oncology and Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Pandya A; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Krumholz HM; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Goshua G; Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut, USA.
Am J Hematol ; 98(9): E247-E250, 2023 09.
Article in En | MEDLINE | ID: mdl-37401660
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Hemophilia A Type of study: Health_economic_evaluation Limits: Adult / Humans Country/Region as subject: America do norte Language: En Journal: Am J Hematol Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Hemophilia A Type of study: Health_economic_evaluation Limits: Adult / Humans Country/Region as subject: America do norte Language: En Journal: Am J Hematol Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos